L A Collins

2.7k total citations · 1 hit paper
15 papers, 2.3k citations indexed

About

L A Collins is a scholar working on Infectious Diseases, Molecular Biology and Molecular Medicine. According to data from OpenAlex, L A Collins has authored 15 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Molecular Medicine. Recurrent topics in L A Collins's work include Antibiotic Resistance in Bacteria (4 papers), Aquaculture disease management and microbiota (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). L A Collins is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Aquaculture disease management and microbiota (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). L A Collins collaborates with scholars based in United States. L A Collins's co-authors include Scott G. Franzblau, Marina N. Torrero, Roger L. Jenkins, W. David Lewis, Matthew H. Samore, Michael Symmons Roberts, A. W. Karchmer, Roberto Luzzati, George M. Eliopoulos and Christine Wennersten and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Applied and Environmental Microbiology and Journal of Bacteriology.

In The Last Decade

L A Collins

15 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

1997 1.4k citations L A Collins, Scott G. Franzblau Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by L A Collins

Since Specialization

Citations

This map shows the geographic impact of L A Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L A Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L A Collins more than expected).

Fields of papers citing papers by L A Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L A Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L A Collins. The network helps show where L A Collins may publish in the future.

Co-authorship network of co-authors of L A Collins

This figure shows the co-authorship network connecting the top 25 collaborators of L A Collins. A scholar is included among the top collaborators of L A Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L A Collins. L A Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Detection ofFrancisella tularensiswithin Infected Mouse Tissues by Using a Hand-Held PCR Thermocycler 2003 ·Journal of Clinical Microbiology ·Peter A. Emanuel, Ryan P. Bell, (unknown), (unknown), J. C. David, Robert J. Burgess, (unknown), L A Collins, Ted L. Hadfield	57
2	Contribution of rpoB Mutations to Development of Rifamycin Cross-Resistance in Mycobacterium tuberculosis 1998 ·Antimicrobial Agents and Chemotherapy ·Diana L. Williams, (unknown), L A Collins, (unknown), Leonid Heifets, P R Gangadharam, Thomas P. Gillis	186
3	Green Fluorescent Protein Reporter Microplate Assay for High-Throughput Screening of Compounds against Mycobacterium tuberculosis 1998 ·Antimicrobial Agents and Chemotherapy ·L A Collins, Marina N. Torrero, Scott G. Franzblau	107
4	Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium breakdown → 1997 ·Antimicrobial Agents and Chemotherapy ·L A Collins, Scott G. Franzblau	1438
5	Antigens ofEdwardsiella ictalurirecognised by serum antibodies from naturally infected channel catfish 1997 ·Fish & Shellfish Immunology ·Thomas J. Baldwin, L A Collins, Joseph C. Newton	18
6	A Comparison of Immersion, Immersion/Oral Combination and Injection Methods for the Vaccination of Channel Catfish Ictalurus punctatus Against Edwardsiella ictaluri 1997 ·Journal of the World Aquaculture Society ·Ronald L. Thune, L A Collins, (unknown)	45
7	Development of a Defined Minimal Medium for the Growth of Edwardsiella ictaluri 1996 ·Applied and Environmental Microbiology ·L A Collins, R. L. Thune	27
8	Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria 1995 ·Antimicrobial Agents and Chemotherapy ·G J Malanoski, L A Collins, C T Eliopoulos, Robert C. Moellering, George M. Eliopoulos	11
9	Risk Factors For Invasive Fungal Infections Complicating Orthotopic Liver Transplantation 1994 ·The Journal of Infectious Diseases ·L A Collins, Matthew H. Samore, Michael Symmons Roberts, Roberto Luzzati, Roger L. Jenkins, W. David Lewis, A. W. Karchmer	227
10	Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp 1994 ·Antimicrobial Agents and Chemotherapy ·L A Collins, Christine Wennersten, Mary Jane Ferraro, R C Moellering, George M. Eliopoulos	7
11	In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms 1993 ·Antimicrobial Agents and Chemotherapy ·L A Collins, George M. Eliopoulos, Christine Wennersten, Mary Jane Ferraro, R C Moellering	29
12	In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria 1993 ·Antimicrobial Agents and Chemotherapy ·G J Malanoski, L A Collins, Christine Wennersten, Robert C. Moellering, George M. Eliopoulos	21
13	In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms 1993 ·Antimicrobial Agents and Chemotherapy ·L A Collins, G J Malanoski, George M. Eliopoulos, Christine Wennersten, Mary Jane Ferraro, Robert C. Moellering	99
14	Mutational analysis reveals functional similarity between NARX, a nitrate sensor in Escherichia coli K-12, and the methyl-accepting chemotaxis proteins 1992 ·Journal of Bacteriology ·L A Collins, Susan M. Egan, Valley Stewart	42
15	In vivo requirement of integration host factor for nar (nitrate reductase) operon expression in Escherichia coli K-12. 1992 ·Proceedings of the National Academy of Sciences ·(unknown), L A Collins, Valley Stewart	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact